IGF1R and breast carcinoma: Carboni et al. (2005[9]) created a transgenic mouse model of breast carcinoma that uses the MMTV promoter to drive the overexpression of the IGF-IR in the salivary and mammary glands, duplicating the overexpression of IGF-IR commonly observed in breast malignancies.